New combined tests deliver highly accurate point-of-care detection for SARS-CoV-2, Flu A, Flu B and RSV – boosting infection control in hospitals and speeding patient access to urgent care.

The GP, who has been NHSE north-west regional director since last year, was appointed to her new role this week.

The test can identify almost half of women who will get breast cancer in the next decade, thus potentially saving the lives of thousands of young people.

Thousands of participants across Greater Manchester area are donating blood samples to this trial of a test aimed at detecting more than 50 types of cancer at an early stage.

New multiplex panel can detect SARS CoV 2, Flu A Flu B RSV at the Point of Need and can deliver accurate PCR results in approximately 30 minutes.

BIVDA welcomes the In Vitro Diagnostic Medical Devices Regulation and urges continued work to deploy the new regulatory system.

Researchers at the University of Swansea have developed a blood test that utilises Artificial Intelligence to identify patterns of cancer leaked into the bloodstream.

This new hub will support nearly 10,000 manufacturers and is an opportunity for SMEs to better utilise their data.

Health and Social Care Committee Chair Jeremy Hunt has criticised the Government for the move.

We welcome the reiteration of Government announcements to boost diagnostic capacity through Community Diagnostic Centres (CDCs) and increased, more efficient testing.